Postoperative nausea and vomiting and opioid-induced nausea and vomiting: guidelines for prevention and treatment;Recomendaciones de prevención y tratamiento de las náuseas y vómitos postoperatorios y/o asociados a las infusiones de opioides

Revista Espanola de Anestesiologia y Reanimacion

Volumn 57, Issue 8, 2010, Pages 508-524

  Gomez Arnau J I ^a   Aguilar, J L ^b   Bovaira, P ^c   Bustos, F ^d   De Andres J ^c   de la Pinta, J C ^e   Garcia Fernandez J ^f   Lopez Alvarez S ^g   Lopez Olaondo L ^h   Neira, F ⁱ   Planas, A ^j   Pueyo, J ^h   Vila, P ^k   Torres, L M ^l  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^b HOSPITAL SON LLÀTZER   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^d HOSPITAL VIRGEN DE LA SALUD   (Spain)

^e Servicio de Psiquiatría de la Fundación Jiménez Díaz de Madrid   (Spain)

^f HOSPITAL INFANTIL LA PAZ   (Spain)

^g HOSPITAL JUAN CANALEJO   (Spain)

^h UNIVERSITY CLINIC OF NAVARRA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

^j HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^k HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^l HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

more..

Author keywords

Analgesia; Clinical practice guidelines; Epidemiology; Opioids; patient controlled; Postoperative nausea; Prevention; Risk factors; Treatment; vomiting

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ADULT; CHEMICALLY INDUCED DISORDER; CHEMOPROPHYLAXIS; CHILD; COST BENEFIT ANALYSIS; DRUG INTERACTION; ECONOMICS; HUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE NAUSEA AND VOMITING; PRACTICE GUIDELINE; REVIEW; RISK FACTOR;

ADULT; ANALGESICS, OPIOID; CHEMOPREVENTION; CHILD; COST-BENEFIT ANALYSIS; DRUG INTERACTIONS; HUMANS; POSTOPERATIVE NAUSEA AND VOMITING; RISK FACTORS;

EID: 80053390144     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0034-9356(10)70711-8     Document Type: Review

References (134)

1. Fisher, D.M., The little problem of postoperative nausea and vomiting. Do we know the answer yet?. Anesthesiology 87:6 (1997), 1271–1273.
2. Apfel, C., Roewer, N., Risk assessment of postoperative nausea and vomiting. Int Anesthesiol Clin 41:4 (2003), 13–32.
3. Gang, T.J., Meyer, T.A., Apfel, C.C., Chung, F., Davis, P.J., Habib, A.S., et al. Society for Ambulatory Anaesthesia Guidelines for the management of postoperative nausea and vomiting. Anesth Analg 105:6 (2007), 1615–1628.
4. Gang, T.J., Meyer, T., Apfel, C.C., Chung, F., Davis, P.J., Eubanks, S., et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 97:1 (2003), 62–71.
5. McCracken, G., Houston, P., Lefebvre, G., Society of Obstetricians and Gynecologists of Canada. Guideline for the management of postoperative nausea and vomiting. J Obstet Gynaecol Can 30:7 (2008), 600–607.
6. Diemunsch, P., Société Française d'Anesthésie et de Réanimation. Conférence d'experts-Text court. Prise en charge des nausées et vomissements postopératoires. Ann Fran Anesth Réanim 27 (2008), 866–878.
7. ASPAN'S evidence-based clinical practice guideline for the prevention and/or management of PONV/PDNV. J Perianesth Nurs 4 (2006), 230–250.
8. Pergolizzi, J.V., PONV unplugged. Semin Anesth Periop Pain Med 23 (2004), 203–220.
9. Wu, C.L., Berenholtz, S.M., Pronovost, P.J., Fleisher, L.A., Systematic review and analysis of postdischarge symptoms after outpatient surgery. Anesthesiology 96:4 (2002), 994–1003.
10. Lichtor, J.L., Glass, PSA., We're tired of waiting. Anesth Analg 107:2 (2008), 353–355.
11. Kovac, A.L., Management of postoperative nausea and vomiting in children. Pediatr Drugs 9:1 (2007), 47–69.
12. Fetzer, S.J., Hand, M.A., Bouchard, P.A., Smith, H.B., Jenkins, M.B., Self-care activities for postdischarge nausea and vomiting. J Perianesth Nurs 20:4 (2005), 249–254.
13. White, P., Sacan, O., Nuangchamnong, N., Sun, T., Eng, M.R., The relationship between patient risk factors and early versus late postoperative emetic symptoms. Anesth Analg 107:2 (2008), 459–463.
14. Gupta, A., Wu, C.L., Elkassabany, N., Krug, C.E., Parker, S.D., Fleisher, L.A., Does the routine prophylactic use of antiemetics affect the incidence of postdischarge nausea and vomiting following ambulatory surgery? A systematic review of randomized controlled trials. Anesthesiology 99:2 (2003), 488–495.
15. Miller, A.D., Central mechanisms of vomiting. Dig Dis Scien 44:8 Suppl (1999), 39S–43S.
16. Hornby, P.J., Central neurocircuitry associated with emesis. Am J Med 111:Suppl. 8A (2001), 106S–112S.
17. Horn, C.C., Why is the neurobiology of nausea and vomiting so important?. Appetite 50:2–5 (2008), 430–434.
18. Sanger, G.J., Andrews, PLR., Treatment of nausea and vomiting: Gaps in our knowledege. Auton Neurosci 129:1–2 (2006), 3–16.
19. Bel, I., Gambús, P., Estratificación del riesgo, profilaxis y tratamiento de las náuseas y vómitos postoperatorios. Rev Esp Anestesiol Reanim 53:5 (2006), 301–311.
20. Gibbison, B., Spencer, R., Post-operative nausea and vomiting. Anaesth Intensive Care Med 10 (2009), 583–585.
21. Ruiz, J.R., Kee, S.S., Frenzel, J.C., Encor, J.E., Selvan, M., Risdel, B.J., et, al., The Effect of an anatomically classified procedure on antiemetic administration in the postanesthesia care unit. Anesth Analg 110:2 (2010), 403–409.
22. Toner, C.C., Broomhead, C.J., Littlejohn, I.H., Samra, G.S., Powney, J.G., Palazzo, M.G., et al. Prediction of postoperative nausea and vomiting using a logistic regression model. Br J Anaesth 76 (1996), 347–351.
23. Koivuranta, M., Läärä, E., Snare, L., Alahuhta, S., A survey of postoperative nausea and vomiting. Anaesthesia 52:5 (1997), 443–449.
24. Apfel, C., Läärä, E., Koivuranta, M., Greim, C., Roewer, N., A simplified risk score for predicting postoperative nausea and vomiting. Anesthesiology 91:3 (1999), 693–700.
25. Fernández-Guisasola, J., Gómez-Arnau, J.I., Cabrera, Y., García del Valle, S., Association between nitrous oxide and the incidence of postoperative nausea and vomiting in adults: a systematic review and meta-analysis. Anaesthesia 65 (2010), 379–387.
26. Palazzo, M., Evans, R., Logistic regression analysis of fixed patient factors for postoperative sickness: a model for risk assessment. Br J Anaesth, 70, 1993, 135.
27. Sinclair, D., Chung, F., Mezei, G., Can postoperative nausea and vomiting be predicted?. Anesthesiology 91:1 (1999), 109–118.
28. Henzi, I., Sonderegger, J., TrÀmer, M.R., Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Can J Anesth 47:6 (2000), 537–551.
29. Habib, A., Gan, T.J., Evidence-based management of postoperative nausea and vomiting: a review. Can J Anesth 51:4 (2004), 326–341.
30. Sneyd, J.R., Droperidol: past, present and future. Anaesthesia 64:11 (2009), 1161–1167.
31. Henzi, I., Walder, B., TrÀmer, M.R., Metoclopramide in the prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized, placebo-controlled studies. Br J Anaesth 83:5 (1999), 761–771.
32. Delás, F.J., Ros, J., Ledesma, M., López-Rodríguez, M., Fernández-Martínez, M.A., Villalonga, A., Prevención de las náuseas y vómitos postoperatorios en cirugía ginecológica mediante tres dosis fijas de metoclopramida, droperidol o placebo. Rev Esp Anestesiol Reanim 48:1 (2001), 65–68.
33. Wallenborn, J., Gelbrich, G., Bulst, D., Behrends, K., Wallenborn, H., Rohrbach, A., et al. Prevention of postoperative nausea and vomiting by metoclopramide combined with dexamethasone: randomised double blind multicentre trial. BMJ 333 (2006), 324–329.
34. Quaynor, H., Raeder, J.C., Incidence and severity of postoperative nausea and vomiting are similar after metoclopramide 20 mg and ondansetron 8 mg given by the end of laparoscopic cholecystectomies. Acta Anaesthesiol Scand 46:1 (2002), 109–113.
35. Kranke, P., Schuster, F., Eberhart, L.H., Recent advances, trends, and economic considerations in the risk assessment, prevention and treatment of postoperative nausea and vomiting. Expert Opin Pharmacother 8:18 (2007), 3217–3235.
36. Le, T.P., Gan, T.J., Update on the managent of postoperative nausea and vomiting and postdischarge nausea and vomiting in ambulatory surgery. Anesthesiol Clin 28:2 (2010), 225–249.
37. Henzi, I., Walder, B., TrÀmer, M.R., Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 90:1 (2000), 186–194.
38. TrÀmer, M.R., Reynolds, D.J., Moore, R.A., McQuay, H.J., Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebo-controlled trials. Anesthesiology 87:6 (1997), 1277–1289.
39. Figueredo, E., Canosa, L., Prophylactic ondansetron for postoperative emesis. Meta-analysis of its effectiveness in patients with previous history of postoperative nausea and vomiting. Acta Anaesthesiol Scand 43:6 (1999), 637–644.
40. Muchatuta, N.A., Paech, M.J., Management of postoperative nausea and vomiting: focus on palonosetron. Ther Clin Risk Manage 5:1 (2009), 21–34.
41. Rojas, C., Stathis, M., Thomas, A.G., Massuda, E.B., Alt, J., Zhang, J., et al. Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor. Anesth Analg 107:2–3 (2008), 469–478.
42. Candiotti, K.A., Bimbach, D.J., Lubarsky, D.A., Nhuch, F., Kamat, A., Koch, W.H., et al. The impact of pharmacogenomics on postoperative nausea and vomiting. Anesthesiology 102:3 (2005), 543–549.
43. Kovac, A.L., Prophylaxis of postoperative nausea and vomiting: controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonists. J Clin Anesth 18:4 (2006), 304–318.
44. Ho, K.Y., Gan, T.J., Pharmacology, pharmacogenetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting. Curr Opin Anaesthesiol 19:6 (2006), 606–611.
45. Curran, M.P., Robinson, D.M., Aprepitant: a review of its use in the prevention of nausea and vomiting. Drugs 69:13 (2009), 1853–1857.
46. Apfel, C.C., Malhotra, A., Leslie, J.B., The role of neurokinin-1 receptor antagonists for the management of postoperative nausea and vomiting. Curr Opin Anesthesiol 21:4 (2008), 427–432.
47. Rowbotham, D.J., Recent advances in the non-pharmacological management of postoperative nausea and vomiting. Br J Anaesth 95:1 (2005), 77–81.
48. Scuderi, P.E., James, R.L., Harris, L., Mims III., G.R., Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparoscopy. Anesth Analg 91:6 (2000), 1408–1414.
49. Eberhart, L.H., Mauch, M., Morin, A.M., Wulf, H., Geldner, G., Impact of a multimodal anti-emetic prophylaxis on patient satisfaction in high-risk patients for postoperative nausea and vomiting. Anaesthesia 57:10 (2002), 1022–1027.
50. Apfel, C.C., Korttila, K., Abdalla, M., Kerger, H., Turan, A., Vedder, I., et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 350:24 (2004), 2441–2451.
51. Kovac, A.L., Meta-analysis of the use of rescue antiemetics following PONV prophylactic failure with 5-HT3 antagonist/dexamethasone versus single-agent therapies. Ann Pharmacother 40:5 (2006), 873–887.
52. Eberhart, LHJ, Frank, S., Lange, H., Morin, A.M., Scherag, A., Wulf, H., et al. Systematic review on the recurrence of postoperative nausea and vomiting after a first episode in the recovery room-implications for the treatment of PONV and related clinical trials. BMC Anesthesiology, 6, 2006, 14.
53. Kazemi-Kjellberg, F., Henzi, I., TrÀmer, M.R., Treatment of established postoperative nausea and vomiting: a quantitative systematic review. BMC Anesthesiology, 1, 2001, 2.
54. White, P.F., Droperidol: a cost-effective antiemetic for over thirty years. Anesth Analg 95:4 (2002), 789–790.
55. Unlugenc, H., Guler, T., Gunes, Y., Isik, G., Comparative study of the antiemetic efficacy of ondansetron, propofol and midazolam in the early postoperative period. Eur J Anaesthesiol 21:1 (2004), 60–65.
56. Kovac, A.L., O'Connor, T.A., Pearman, M.H., Kekoler, L.J., Edmondson, D., Baughman, V.L., et al. Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo controlled multicenter trial. J Clin Anesth 11:6 (1999), 453–459.
57. Habib, A.S., Gan, T.J., The effetiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report. J Clin Anesth 17:1 (2005), 62–65.
58. Wolf, H., Preclinical and clinical pharmacology of the 5Ht3 receptor antagonists. Scand J Rheumatol 29:Suppl 113 (2000), 37–45.
59. Dimmitt, D.C., Cramer, M.B., Keung, A., Arumugham, T., Weir, S.J., Pharmacokynetics of dolasetron with coadministration of cimetidine or rifampin in cancer patients. Cancer Chemother Pharmacol 43:2 (1999), 126–132.
60. Leslie, J.B., Gan, T.J., Meta-Analysis of the safety of 5-HT3 antagonists with dexamethasone or droperidol for prevention of PONV. Ann Pharmacother 40:5 (2006), 856–872.
61. Baguley, W.A., Hay, W.T., Mackie, K.P., Cheney, F.W., Cullen, B.F., Cardiac dysrhythmias associated with the intravenous administration of ondansetrón and metoclopramide. Anesth Analg 84:6 (1997), 1380–1381.
62. Grenier, Y., Drolet, P., Asystolic cardiac arrest: an unusual reaction following iv metoclopramide. Can J Anesth 50:4 (2003), 333–335.
63. Fortney, J.T., Gan, T.J., Graczyk, S., Wetchler, B., Melson, T., Khalil, S., et al. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups. Anesth Analg 86:4 (1998), 731–738.
64. TrÀmer, M.R., Walder, B., Efficacy and adverse effects of prophylactic antiemetics during patient-controlled analgesia therapy: a quantitative systematic review. Anesth Analg 88 (1999), 1354–1361.
65. Drolet, B., Zhang, S., Deschênes, D., Rail, J., Nadeau, S., Zhou, Z., et al. Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current. J Cardiovasc Electrophysiol 10:12 (1999), 1597–1604.
66. Gómez-Arnau, J.I., Droperidol y arritmias cardiacas. Rev Esp Anestesiol Reanim 50:4 (2003), 221–224.
67. Charbit, B., Albaladejo, P., Funck-Brentano, C., Legrand, M., Samain, E., Marty, J., Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 102:6 (2005), 1094–1100.
68. White, P.F., Song, D., Abrao, J., Klein, K.W., Navarette, B., Effect of low-dose droperidol on the QT interval during and after general anesthesia. Anesthesiology 102:6 (2005), 1101–1105.
69. Scuderi, P.E., You (still) can't disprove the existence of dragons. Anesthesiology 102:6 (2005), 1081–1082.
70. Nuttall, G.A., Eckerman, K.M., Jacob, K.A., Pawlaski, E.M., Wigersma, S.K., Marieneau, MES, et al. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?. Anesthesiology 107:4 (2007), 531–536.
71. Habib, A.S., Gan, T.J., PRO: The Food and Drug Administration black box warning on droperidol is not justified. Anesth Analg 106:5 (2008), 1414–1417.
72. Roden, D., Drug induced prolongation of the QT interval. N Engl J Med 350:10 (2004), 1013–1022.
73. Sánchez-Ledesma, M.J., López-Olaondo, L., Pueyo, F.J., Carrascosa, F., Ortega, A., A comparison of three antiemetic combinations for the prevention of postoperative nausea and vomiting. Anesth Analg 95:6 (2002), 1590–1595.
74. Williams, O.A., Middleton, M., Henderson, P., Reilly, C.S., Stability of morphine and droperidol, separately and combined, for use as infusion. Hosp Pharm Prac 2 (1992), 597–600.
75. Longstreth GF, Hesketh PJ. Characteristics of antiemetic drugs, last updated: Julio 2009. Disponible en: http://www.uptodate.com/online/content/topic.do?topic-Key=gi_dis/12256&swelectedTitle=1%7E150&sou=search_result. Accedido en Septiembre 2009.
76. Hesketh, P.J., Chemotherapy-induced nausea and vomiting. N Engl J Med 358 (2008), 2482–2494.
77. Bolton, C.M., Myles, P.S., Nolan, T., Sterne, J.A., Prophylaxis of postoperative vomiting in children undergoing tonsillectomy: a systematic review and meta-analysis. Br J Anaesth 97:5 (2006), 593–604.
78. Fujii, Y., Current management of vomiting after tonsillectomy in children. Curr Drug Saf 4:1 (2009), 62–73.
79. Engelman, E., Salengros, J.C., Barvais, L., How much does pharmacologic prophylaxis reduce postoperative vomiting in children? Calculation of prophylaxis effectiveness and expected incidence of vomiting under treatment using Bayesian meta-analysis. Anesthesiology 109:6 (2008), 1023–1035.
80. Kim, M.S., Coté, C.J., Cristoloveanu, C., Roth, A.G., Vornov, P., Jennings, M.A., et al. There is no dose escalation response to dexamethasone (0,0625–1,0 mg/Kg) in pediatric tonsillectomy or adenotonsillectomy patients for preventing vomiting, reducing pain, shortening time to first liquid intake, or the incidence of voice change. Anesth Analg 104 (2007), 1052–1058.
81. Eberhart, L.H., Geldner, G., Kranke, P., Morin, A.M., Schauffelen, A., Treiber, H., et al. The development and validation of a risk score to predict the probability of postoperative vomiting in pediatric patients. Anesth Analg 99:6 (2004), 1630–1637.
82. Stead, S.W., Beatie, C.D., Keyes, M.A., Isenberg, S.J., Effects of droperidol dosage on postoperative emetic symptoms following pediatric strabismus surgery. J Clin Anesth 16:1 (2004), 34–39.
83. McKeage, K., Simpson, D., Wagstaff, A.J., Intravenous droperidol: a review of its use in the management of postoperative nausea and vomiting. Drugs 66:16 (2006), 2123–2147.
84. Watcha, M.F., Management of postoperative vomiting in pediatric patients. Curr Opin Anaesthesiol 16:6 (2003), 575–583.
85. Carroll, N.V., Miederhoff, P., Cox, F.M., Hirsch, J.D., Postoperative nausea and vomiting after discharge from outpatient surgery centers. Anesth Analg 80:5 (1995), 903–909.
86. Salamanca-Montaña, M.E., López-Alvárez, S., Cobian-Llamas, J.M., Náuseas y vómitos postoperatorios en Cirugía Ambulatoria. Cir May Amb 30 (2005), 13–18.
87. Kolodzie, K., Apfel, C.C., Nausea and vomiting after office-based anesthesia. Curr Opin Anesthesiol 22:4 (2009), 532–538.
88. Peiró, C.M., Errando, C., Náuseas y vómitos postoperatorios en anestesia regional y tratamiento del dolor. De Andrés, J., (eds.) Puesta al dia en anestesia regional y tratamiento del dolor, 2006, MRA Ed, Barcelona.
89. Apfel, C.C., Nausea and vomiting in day case anaesthesia: risk score, prophylaxis and rescue therapy. Refresher Course 02RC2, Euroanaesthesia, 2010.
90. Pan, P.H., Lee, S.C., Harris, L.C., Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting and Impact on Functional Quality of Living During Recovery in Patients with High Emetic Risks: A Prospective, Randomized, Double-Blind Comparison of Two Prophylactic Antiemetic Regimens. Anesth Analg 107 (2008), 429–438.
91. Gupta, A., Stierer, T., Zuckerman, R., Sakima, N., Parker, S.D., Fleisher, L.A., Comparison of recovery profile after ambulatory anesthesia with propofol, isoflurane, sevoflurane and desflurane: a systematic review. Anesth Analg 98:3 (2004), 632–641.
92. Kovac, K.L., Eberhart, L., Kotarski, J., Clerici, G., Apfel, C.C., Palonosetron 04–07 Study Group. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period. Anesth Analg 107:2 (2008), 439–444.
93. Gan, T.J., Apfel, C.C., Kovac, A., Philip, B.K., Singla, N., Minkowitz, H., et al. Aprepitant-PONV Study Group. A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting. Anesth Analg 104:5 (2007), 1082–1089.
94. Glass, P.S., White, P.F., Practice Guidelines for the management of postoperative nausea and vomiting: Past, present and future. Anesth Analg 105:6 (2007), 1528–1529.
95. Gan, T.J., Franiak, R., Reeves, J., Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery. Anesth Analg 94:5 (2002), 1199–1200.
96. Zarate, E., Mingus, M., White, P.F., Chiu, J.W., Scuderi, P., Loskota, W., et al. The use of transcutaneous acupoint electrical stimulation for preventing nausea and vomiting after laparoscopic surgery. Anesth Analg 92 (2001), 629–635.
97. Bailey, P.L., Streisand, J.B., Pace, N.L., Bubbers, S.J., East, K.A., Mulder, S., et al. Transdermal scopolamine reduces nausea and vomiting after outpatient laparoscopy. Anesthesiology 72:6 (1990), 977–980.
98. Lamond, C.T., Robinson, D.L., Boyd, J.D., Cashman, J.N., Addition of droperidol to morphine administered by the patient-controlled analgesia method: what is the optimal dose?. Eur J Anaesthesiol 15:3 (1998), 304–309.
99. Walder, B., Schaffer, M., Henzi, I., TrÀmer, M.R., Efficacy and safety of patient-controlled opioid analgesia foe acute postoperative pain: A quantitative systemetic review. Acta Anaesthesiol Scand 45:7 (2001), 795–804.
100. Culebras, X., Corpataux, J.B., Gaggero, G., TrÀmer, M., The antiemetic efficacy of droperidol added to morphine patient-controlled analgesia: A randomized, controlled, multicenter dose-finding study. Anesth Analg 97:3 (2003), 816–821.
101. Collado, M.C., Aragón, M.C., Pérez, A.C., Eizaga, R., Vidal, M.A., Torres, L.M., Organización de una Unidad de Dolor Agudo en un hospital Regional. Rev Soc Esp Dolor 15 (2008), 28–40.
102. Roberts, G.W., Bekker, T.B., Carlsen, H.H., Moffatt, C.H., Slattery, P.J., McClur, A.F., Postoperative nausea and vomiting are strongly influenced by postoperative opioid use in a dose-related manner. Anesth Analg 101 (2005), 1343–1348.
103. Zhao, S.Z., Chung, F., Hanna, D.B., Raymundo, A.L., Cheung, R.Y., Chen, C., Dose-response relationship between opioid use and adverse effects after ambulatory surgery. J Pain Symptom Manage 28:1 (2004), 35–46.
104. Bailey, P.L., Rhondeau, S., Schaffer, P.G., Lu, J.K., Timmins, B.S., Foster, W., et al. Dose-response pharmacology of intratecal morphine in human volunteers. Anesthesiology 79 (1993), 49–59.
105. Rama-Maceiras, P., Ferreira, T.A., Molins, N., Sanduende, Y., Bautista, A.P., Rey, T., Less postoperative nausea and vomiting after propofol + remifentanil versus propofol + fentanyl anaesthesia during plastic surgery. Acta Anaesthesiol Scand 49:3 (2005), 305–311.
106. Johnston, K.D., The potential for mu-opioid receptor agonists to be antiemetic in humans: a review of clinical data. Acta Anaesthesiol Scand 54:2 (2010), 132–140.
107. Apfel, C.C., Jalota, L., Can central antiemetic effects of opioids counterbalance opioid-induced nausea and vomiting?. Acta Anaesthesiol Scand 54:2 (2010), 129–131.
108. McNicol, E., Horowicz-Mehler, N., Fisk, R.A., Bennett, K., Gialeli-Goudas, M., Chew, P.W., et al. Management of opioid side-effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 4:5 (2003), 231–256.
109. Swegle, J.M., Logemann, C., Management of common opioid-induced adverse effects. Am Fam Physician 74:8 (2006), 1347–1354.
110. Taguchi, A., Sharma, N., Saleem, R.M., Sessler, D.I., Carpenter, R.L., Seyedsadr, M., et al. Selective postoperative inhibition of gastrointestinal opioid receptors. N Engl J Med 345:13 (2001), 935–940.
111. Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. Acute Pain Management. Scientific Evidence, 2nd Ed. (Consultado 1 Diciembre 2009). Disponible en http://www.anzca.edu.au/resources/booksandpublications/acutepain.pdf and publications/acutepain.pdf.
112. Lo, Y., Chia, Y.Y., Liu, K., Ko, N.H., Morphine sparing with droperidol in patient-controlled analgesia. J Clin Anesth 17 (2005), 271–275.
113. Ng, K.F., Tsui, S.L., Yang, J.C., Ho, E.T., Comparison of tramadol and tramadol/droperidol mixture for patient-controlled analgesia. Can J Anesth 44 (1997), 810–815.
114. Cuéllar, E., Méndez, D., Medina, A., Hinojosa, A., Partal, S., Sabatel, M.A., et al. Analgesia intravenosa controlada por el paciente: tramadol vs tramadol + droperidol en cirugía digestiva. Control de náuseas y vómitos postoperatorios. Rev Soc Esp Dolor 8 (2001), 253–259.
115. Rung, G.W., Claybon, L., Hord, A., Patel, C., Kallgren, M., Koppel, J., et al. Intravenous ondansetron for postsurgical opioid-induced nausea and vomiting. Anesth Analg 84:4 (1997), 659–668.
116. Chung, F., Lane, R., Spraggs, C., McQuade, B., Jacka, M., Luttropp, H.H., et al. Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients. Eur J Anaesthesiol 16:10 (1999), 669–677.
117. De, Witte JL, Schoenmakers, B., Sessler, D.I., Deloof, T., The analgesic efficacy of tramadol is impaired by concurrent administration of ondansetron. Anesth Analg 92:5 (2001), 1319–1321.
118. Arcioni, R., della Oca, M., Romano, S., Romano, R., Pietropaoli, P., Gasparetto, A., Ondansetron inhibits the analgesic effects of tramadol: A possible 5-HT3 spinal involvement in acute pain in humans. Anesth Analg 94:6 (2002), 1553–1557.
119. Dürsteler, C., Mases, A., Puig, M.M., Universal PONV prophylaxis in general anesthesia: Should we consider its immediate implementation?. Anesth Analg, 106(6), 2008, 1922.
120. Jellish, W.S., Owen, K., Fluder, E., Sawicki, K., Sinacore, J., Patient-controlled analgesia with either ondansetron or ondansetron plus prochlorperazine for control of pain and nausea and vomiting in patients undergoing abdominal surgery. J Clin Anesth 20:8 (2008), 594–600.
121. Marret, E., Kurdi, O., Zufferey, P., Bonnet, F., Effects of nonsteroidal antiinflamatory drugs on patient-controlled analgesia morphine side effects. Meta-analysis of randomized controlled trials. Anesthesiology 102:6 (2005), 1249–1260.
122. Huh, B.K., Jung, S., White, W., Jeon, Y., Anti-emetic effect of midazolam added to morphine patient-controlled analgesia after total abdominal hysterectomy. Anaesth Intensive Care 83 (2010), 481–485.
123. Naji, P., Farschtschian, M., Wilder-Smith, O.H., Wilder-Smith, C.H., Epidural droperidol and morphine for postoperative pain. Anesth Analg 70:6 (1990), 583–588.
124. Carlisle JB, Stevenson CA. Fármacos para la prevención de náuseas y vómitos postoperatorios (revisión Cochrane traducida). En: Biblioteca Cochrane Plus, 2008, nº 4. Oxford: Update Ltd. Disponible en http://www.update-software.com.
125. Tang, J., Watcha, M.F., White, P.F., A comparison of costs and efficacy of ondansetron and droperidol as prophylactic antiemetic therapy for elective outpatient gynecologic procedures. Anesth Analg 83:2 (1996), 304–313.
126. Hill, R.P., Lubarsky, D.A., Phillips-Bute, B., Fortney, J.T., Creed, M.R., Glass, P.S., Gan, T.J., Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology 92:4 (2000), 958–967.
127. Fortney, J.T., Gan, T.J., Graczyk, S., Wetchler, B., Melson, T., Khalil, S., et al. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups. Anesth Analg 86:4 (1998), 731–738.
128. Frighetto, L., Loewen, P.S., Dolman, J., Marra, C.A., Cost-effectiveness of prophylactic dolasetron or droperidol vs rescue therapy in the prevention of PONV in ambulatory gynecologic surgery. Can J Anesth 46:6 (1999), 536–543.
129. Pueyo, F.J., López-Olaondo, L., Sanchez-Ledesma, M.J., Ortega, A., Carrascosa, F., Cost-effectiveness of three combinations of antiemetics in the prevention of postoperative nausea and vomiting. Br J Anaesth 91:4 (2003), 589–592.
130. Watcha, M.F., Smith, I., Cost-effectiveness analysis of antiemetic therapy for ambulatory surgery. J Clin Anesth 6:5 (1994), 370–377.
131. Kranke, P., Schuster, F., Eberhart, L.H., Recent advances, trends and economic considerations in the risk assessment, prevention and treatment of postoperative nausea and vomiting. Expert Opin Pharmacother 8:18 (2007), 3217–3235.
132. Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA 268 (1992), 2420–2425.
133. Sackett, D.L., Rosenberg, WMC, Gary, JAM, Haynes, R.B., Richardson, W.S., Evidence based medicine: what is it and what it isn't. BMJ 312 (1996), 71–72.
134. Harris, R.P., Helfand, M., Woolf, S.H., Lohr, K.N., Mulrow, C.D., Teutsch, S.M., et al. Current methods of the US Preventive Services Task Force: A review of the process. Am J Prev Med 20:3S (2001), 21–35.